HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 85 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,286,616 | -8.6% | 39,262 | -1.8% | 0.00% | 0.0% |
| Q2 2023 | $1,407,002 | +40.9% | 39,983 | +30.7% | 0.00% | +100.0% |
| Q1 2023 | $998,861 | -41.6% | 30,593 | -1.5% | 0.00% | -66.7% |
| Q4 2022 | $1,711,351 | +25.4% | 31,059 | +0.8% | 0.00% | +50.0% |
| Q3 2022 | $1,365,000 | -10.1% | 30,809 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,519,000 | +26.1% | 31,147 | +25.8% | 0.00% | 0.0% |
| Q1 2022 | $1,205,000 | +4.6% | 24,763 | -8.4% | 0.00% | +100.0% |
| Q4 2021 | $1,152,000 | +15.2% | 27,027 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $1,000,000 | +15.1% | 26,080 | -15.3% | 0.00% | 0.0% |
| Q2 2021 | $869,000 | +180.3% | 30,786 | +227.8% | 0.00% | – |
| Q1 2021 | $310,000 | -8.8% | 9,393 | 0.0% | 0.00% | – |
| Q4 2020 | $340,000 | – | 9,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
| venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
| Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
| Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
| AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |